Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Regeneron (NASDAQ: REGN) Delayed: 827.72 -15.75 (1.87%)
Previous Close $843.47    52 Week High $592.36 
Open $840.05    52 Week Low $325.35 
Day High $841.54    P/E 217.25 
Day Low $825.83    EPS $3.81 
Volume 561,170